Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_37105 | 54 | 1.13 | Mlig455_057732 | Neo: - Age: - |
ANGPTL1 | Mlig455_057732 {REF} {Length: 2404} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=107.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=94.7, Expect=8e-21]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=90.9, Expect=1e-19]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=92.8, Expect=2e-20]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=90.9, Expect=9e-20]} {Dmel: FBgn0050280, CG30280, [Score=88.6, Expect=6e-20]} {Celegans: WBGene00017013, ensh-1, [Score=61.6, Expect=2e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=85.1, Expect=5e-18]} {RNA1509_49031} {RNA1310_45132} {RNA815_44160} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.236 | 1.529 | 0.99974 | 1.00000 | |
RegionR2 | 0.959 | 1.529 | 0.49101 | 0.87245 | |
RegionR3 | 1.191 | 1.529 | 0.35392 | 0.88937 | |
RegionR4 | 2.499 | 1.529 | 0.04763 | 0.18650 | |
RegionR5 | -0.134 | 1.529 | 0.81918 | 1.00000 | |
RegionR6 | -0.329 | 1.529 | 0.86315 | 1.00000 | |
RegionR7 | 0.652 | 1.529 | 0.65477 | 1.00000 | |
RegionR8 | -2.603 | 1.529 | 0.99961 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.823 | 1.529 | 0.99994 | 1.00000 | |
RegenerationR2 | 0.745 | 1.529 | 0.38893 | 0.80796 | |
RegenerationR3 | 0.8 | 1.529 | 0.43667 | 0.82507 | |
RegenerationR4 | -0.77 | 1.529 | 0.39677 | 0.81105 | |
RegenerationR5 | 0.96 | 1.529 | 0.34324 | 0.75985 | |
RegenerationR6 | 2.065 | 1.529 | 0.09001 | 0.37362 | |
RegenerationBL | 1.805 | 1.529 | 0.34728 | 0.71459 | |
RegenerationTP | 2.048 | 1.529 | 0.38839 | 0.82157 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_37105 | 54 | 1.13 | Mlig455_057732 | Neo: - Age: - |
ANGPTL1 | 4 | 1.000 | - | - | 1.000 | 1.000 | 1.000 | Mlig455_057732 {REF} {Length: 2404} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=107.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=94.7, Expect=8e-21]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=90.9, Expect=1e-19]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=92.8, Expect=2e-20]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=90.9, Expect=9e-20]} {Dmel: FBgn0050280, CG30280, [Score=88.6, Expect=6e-20]} {Celegans: WBGene00017013, ensh-1, [Score=61.6, Expect=2e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=85.1, Expect=5e-18]} {RNA1509_49031} {RNA1310_45132} {RNA815_44160} |
2. | MligTC455_51246 | 58 | 1.2 | Mlig455_014016 | Neo: - Age: - |
1.894 | - | - | - | 0.955 | - | 0.939 | Mlig455_014016 {REF} {Length: 2834} {NoTransDecoderORF} {RNA1509_57004} {RNA1310_22299} {RNA815_15623} | |
3. | MligTC455_41083 | 27 | 0.57 | Mlig455_034126 | Neo: - Age: - |
1.727 | - | - | - | - | 0.771 | 0.956 | Mlig455_034126 {REF} {Length: 1904} {NoTransDecoderORF} {RNA1310_47812} {RNA815_46461} | |
4. | MligTC455_32436 | 43 | 0.91 | Mlig455_025074 | Neo: - Age: - |
1.725 | - | - | - | - | 0.761 | 0.964 | Mlig455_025074 {REF} {Length: 2851} {RNA1509_1845} {RNA1310_50.1} {RNA815_5933} | |
5. | MligTC455_38278 | 50 | 1.04 | Mlig455_014927 | Neo: - Age: - |
NOL4L | 1.691 | - | - | - | 0.960 | - | 0.731 | Mlig455_014927 {REF} {Length: 2062} {Human: ENSG00000197183, NOL4L, nucleolar protein 4 like, [RH, Score=149, Expect=3e-39]} {Mouse: ENSMUSG00000061411, Nol4l, nucleolar protein 4-like, [RH, Score=149, Expect=4e-39]} {Dmel: FBgn0283651, CG46301, [RH, Score=146, Expect=3e-37]} {Smed: dd_Smed_v6_27580_0_1, dd_Smed_v6_27580_0_1, [RH, Score=83.2, Expect=5e-17]} {RNA1310_111241} {RNA815_49535} |
6. | MligTC455_38998 | 37 | 0.78 | Mlig455_029952 | Neo: - Age: - |
1.688 | - | - | - | 0.734 | - | 0.954 | Mlig455_029952 {REF} {Length: 4946} {RNA1509_32599} {RNA1310_1659} {RNA815_252.2} | |
7. | MligTC455_09591 | 9 | 0.18 | Mlig455_023068 | Neo: - Age: - |
0.985 | - | - | - | 0.985 | - | - | Mlig455_023068 {REF} {Length: 884} {RNA1310_125147} | |
8. | MligTC455_34279 | 55 | 1.15 | Mlig455_056988 | Neo: - Age: - |
ZBTB16 | 0.985 | - | - | - | 0.985 | - | - | Mlig455_056988 {REF} {Length: 3794} {Pfam: C2H2-type zinc-finger domain [PF13909.8, score=57.5]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=23.3]} {Human: ENSG00000109906, ZBTB16, zinc finger and BTB domain containing 16, [Score=52.8, Expect=2e-06]; ENSG00000084093, REST, RE1 silencing transcription factor, [Score=52.0, Expect=5e-06]} {Mouse: ENSMUSG00000026135, Zfp142, zinc finger protein 142, [Score=62.4, Expect=3e-09]} {Dmel: FBgn0262160, CG9932, [RH, Score=66.6, Expect=9e-11]} {Celegans: WBGene00001824, hbl-1, Hunchback-like protein, [Score=50.4, Expect=6e-06]} {Smed: dd_Smed_v6_36433_0_1, dd_Smed_v6_36433_0_1, [Score=176, Expect=9e-48]} {RNA1509_19024} {RNA1310_45424} {RNA815_39699} |
9. | MligTC455_10906 | 18 | 0.38 | Mlig455_034473 | Neo: - Age: - |
0.984 | - | - | - | 0.984 | - | - | Mlig455_034473 {REF} {Length: 1571} {RNA1509_25022} {RNA1310_121238} {RNA815_3404} | |
10. | MligTC455_39752 | 68 | 1.41 | Mlig455_003074 | Neo: - Age: - Region-enriched R2: 3.667/0.04790 |
SBK1 | 0.982 | - | - | - | 0.982 | - | - | Mlig455_003074 {REF} {Length: 1737} {Pfam: Protein kinase domain [PF00069.27, score=155.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=101.0]; Kinase-like [PF14531.8, score=22.6]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.3]} {Human: ENSG00000188322, SBK1, SH3 domain binding kinase 1, [RH, Score=262, Expect=9e-84]} {Mouse: ENSMUSG00000042978, Sbk1, SH3-binding kinase 1, [RH, Score=263, Expect=2e-84]} {Dmel: FBgn0031855, CG11221, [RH, Score=224, Expect=4e-69]} {Celegans: WBGene00015293, C01C4.3, Putative serine/threonine-protein kinase C01C4.3, [RH, Score=184, Expect=5e-55]} {Smed: dd_Smed_v6_12166_0_1, dd_Smed_v6_12166_0_1, [Score=109, Expect=5e-26]} {RNA1310_28583} {RNA815_17334} |
11. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 0.981 | - | - | - | 0.981 | - | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
12. | MligTC455_21210 | 58 | 1.21 | Mlig455_054815, Mlig455_054824 | Neo: - Age: - |
0.98 | - | - | - | 0.980 | - | - | Mlig455_054815 {REF} {Length: 1627} {Celegans: WBGene00044176, C30G7.2, [Score=80.9, Expect=2e-19]} {Smed: dd_Smed_v6_8948_0_1, dd_Smed_v6_8948_0_1, [RH, Score=90.9, Expect=9e-24]} {RNA1509_36146} {RNA1310_58910} {RNA815_43112} Mlig455_054824 {REF} {Length: 2264} {Celegans: WBGene00044176, C30G7.2, [Score=80.9, Expect=2e-19]} {Smed: dd_Smed_v6_8948_0_1, dd_Smed_v6_8948_0_1, [RH, Score=90.9, Expect=9e-24]} {RNA1509_36146} {RNA1310_58910} {RNA815_43112} |
|
13. | MligTC455_16358 | 1175 | 24.47 | Mlig455_039878 | Neo: - Age: - Region-specific R2: 4.659 Region-enriched R2: 4.310/0.00000 |
0.977 | - | - | - | 0.977 | - | - | Mlig455_039878 {REF} {Length: 1188} {RNA1509_60020} {RNA1310_35099.1, RNA1509_60020} {RNA1509_60020, RNA815_1356.1} | |
14. | MligTC455_30568 | 16 | 0.33 | Mlig455_049799 | Neo: - Age: - |
0.976 | - | - | - | 0.976 | - | - | Mlig455_049799 {REF} {Length: 212} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_11298} {RNA1310_50420} {RNA815_19826} | |
15. | MligTC455_34066 | 149 | 3.1 | Mlig455_069292 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_069292 {REF} {Length: 832} {NoTransDecoderORF} {RNA1509_20753} {RNA1310_16791} {RNA815_12674.1} | |
16. | MligTC455_40405 | 83 | 1.72 | Mlig455_015672 | Neo: - Age: - Region-enriched R2: 4.956/0.00100 |
CHRNA9 | 0.973 | - | - | - | 0.973 | - | - | Mlig455_015672 {REF} {Length: 3935} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=204, Expect=4e-59]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=202, Expect=2e-58]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=201, Expect=5e-58]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=200, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=5e-57]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=5e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=199, Expect=1e-56]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=197, Expect=3e-55]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=196, Expect=1e-55]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=194, Expect=5e-55]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=8e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=205, Expect=4e-59]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=201, Expect=3e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=201, Expect=4e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=191, Expect=8e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=446, Expect=1e-151]} {RNA1509_18288} {RNA1310_3728} {RNA815_3826.1} |
17. | MligTC455_32179 | 7 | 0.15 | Mlig455_022383 | Neo: - Age: - |
KREMEN2 | 0.972 | - | - | - | 0.972 | - | - | Mlig455_022383 {REF} {Length: 1111} {Pfam: WSC domain [PF01822.21, score=44.5]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=5e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=49.3, Expect=2e-06]} {RNA1310_89673} {RNA815_64813} |
18. | MligTC455_13424 | 708 | 14.75 | Mlig455_044367 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.089 Region-enriched R7: 4.024/0.00101 |
0.971 | - | - | - | 0.971 | - | - | Mlig455_044367 {REF} {Length: 633} {RNA1509_34081, RNA1509_52094} {RNA1310_75122.1, RNA1509_34081, RNA1509_52094} {RNA1509_34081, RNA1509_52094, RNA815_57840} | |
19. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 0.971 | - | - | - | 0.971 | - | - | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
20. | MligTC455_38565 | 45 | 0.93 | Mlig455_054917 | Neo: - Age: - |
PCDH11X | 0.971 | - | - | - | 0.971 | - | - | Mlig455_054917 {REF} {Length: 4432} {Pfam: Cadherin domain [PF00028.19, score=225.5]; Cadherin-like [PF08266.14, score=38.0]} {Human: ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=237, Expect=4e-63]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=236, Expect=3e-63]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=238, Expect=6e-64]; ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=231, Expect=6e-62]; ENSMUSG00000044043, Pcdhb14, protocadherin beta 14, [Score=228, Expect=1e-61]; ENSMUSG00000045876, Pcdhb8, protocadherin beta 8, [Score=227, Expect=1e-61]} {Dmel: FBgn0284247, ds, dachsous, [Score=211, Expect=1e-54]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=168, Expect=9e-42]} {Smed: dd_Smed_v6_7973_0_2, dd_Smed_v6_7973_0_2, [Score=267, Expect=1e-73]} {RNA1310_85042} |
21. | MligTC455_40382 | 81 | 1.7 | Mlig455_008892, Mlig455_016587 | Neo: - Age: Up-Down-Down |
SVOP, SVOPL | 0.971 | - | - | - | 0.971 | - | - | Mlig455_008892 {REF} {Length: 4330} {TRANSSPLICED} {Pfam: Major Facilitator Superfamily [PF07690.18, score=113.2]; Sugar (and other) transporter [PF00083.26, score=80.7]} {Human: ENSG00000166111, SVOP, SV2 related protein, [RH, Score=380, Expect=4e-125]; ENSG00000157703, SVOPL, SVOP like, [RH, Score=365, Expect=5e-120]} {Mouse: ENSMUSG00000042078, Svop, SV2 related protein, [RH, Score=368, Expect=2e-120]; ENSMUSG00000029830, Svopl, SV2 related protein homolog (rat)-like, [RH, Score=361, Expect=2e-118]} {Dmel: FBgn0034956, CG4324, [RH, Score=314, Expect=2e-100]} {Celegans: WBGene00014021, svop-1, Putative transporter svop-1, [RH, Score=364, Expect=2e-119]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [RH, Score=473, Expect=1e-162]} {RNA1509_26220} {RNA1310_11596.2} {RNA815_6500} Mlig455_016587 {REF} {Length: 624} {Human: ENSG00000157703, SVOPL, SVOP like, [Score=51.6, Expect=5e-08]} {Mouse: ENSMUSG00000029830, Svopl, SV2 related protein homolog (rat)-like, [Score=50.1, Expect=1e-07]} {Smed: dd_Smed_v6_3645_0_1, dd_Smed_v6_3645_0_1, [Score=69.3, Expect=1e-14]} {RNA1509_26220} {RNA1310_35696} {RNA815_6500} |
22. | MligTC455_10554 | 573 | 11.93 | Mlig455_037747, Mlig455_069922 | Neo: - Age: - Regeneration-depleted BL: -4.357 |
0.97 | - | - | - | - | - | 0.970 | Mlig455_037747 {REF} {Length: 601} {RNA1509_11182} {RNA1310_30933} {RNA815_1577.1} Mlig455_069922 {REF} {Length: 929} {RNA1509_11182} {RNA1310_9907, RNA1509_11182} {RNA1509_11182, RNA815_1577.1} |
|
23. | MligTC455_19310 | 70 | 1.45 | Mlig455_003091 | Neo: - Age: - Region-enriched R2: 3.267/0.02767 |
SPRED2 | 0.97 | - | - | - | 0.970 | - | - | Mlig455_003091 {REF} {Length: 1347} {Pfam: Sprouty protein (Spry) [PF05210.15, score=59.9]} {Human: ENSG00000198369, SPRED2, sprouty related EVH1 domain containing 2, [RH, Score=70.1, Expect=8e-13]} {Mouse: ENSMUSG00000045671, Spred2, sprouty-related, EVH1 domain containing 2, [RH, Score=70.1, Expect=5e-13]} {Dmel: FBgn0020767, Spred, Sprouty-related protein with EVH-1 domain, [Score=54.3, Expect=6e-08]} {Smed: dd_Smed_v6_14816_0_1, dd_Smed_v6_14816_0_1, [RH, Score=59.3, Expect=6e-11]} {RNA1310_54905} {RNA815_26736} |
24. | MligTC455_20154 | 22 | 0.45 | Mlig455_002425 | Neo: - Age: - |
OTOP2 | 0.969 | - | - | - | 0.969 | - | - | Mlig455_002425 {REF} {Length: 2659} {Pfam: Otopetrin [PF03189.15, score=233.1]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=55.1, Expect=3e-07]} {Mouse: ENSMUSG00000050201, Otop2, otopetrin 2, [Score=62.4, Expect=1e-09]} {Dmel: FBgn0259150, CG42265, [Score=197, Expect=2e-52]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=117, Expect=6e-27]} {Smed: dd_Smed_v6_13612_0_4, dd_Smed_v6_13612_0_4, [Score=296, Expect=3e-91]} {RNA1310_52344} {RNA815_48323} |
25. | MligTC455_33394 | 29 | 0.6 | Mlig455_020353, Mlig455_041292 | Neo: - Age: - |
RASGRP1, RASGRP3 | 0.969 | - | - | - | 0.969 | - | - | Mlig455_020353 {REF} {Length: 2230} {Pfam: RasGEF domain [PF00617.21, score=61.8]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=51.4]; EF hand [PF00036.34, score=33.2]; EF-hand domain [PF13405.8, score=32.5]; EF-hand domain pair [PF13499.8, score=28.5]; EF hand [PF13202.8, score=28.0]} {Human: ENSG00000152689, RASGRP3, RAS guanyl releasing protein 3, [Score=360, Expect=2e-115]; ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [Score=349, Expect=6e-110]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [Score=356, Expect=2e-114]} {Dmel: FBgn0003093, Pkc98E, Protein C kinase 98E, [Score=65.1, Expect=9e-11]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=302, Expect=3e-94]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [Score=270, Expect=3e-85]} {RNA1310_83329} Mlig455_041292 {REF} {Length: 3588} {Pfam: RasGEF domain [PF00617.21, score=145.2]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=52.4]; EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.3]; EF-hand domain pair [PF13499.8, score=30.9]; EF hand [PF13202.8, score=29.5]; EF-hand domain pair [PF13833.8, score=19.2]} {Human: ENSG00000172575, RASGRP1, RAS guanyl releasing protein 1, [RH, Score=451, Expect=8e-148]} {Mouse: ENSMUSG00000071042, Rasgrp3, RAS, guanyl releasing protein 3, [RH, Score=453, Expect=2e-150]; ENSMUSG00000027347, Rasgrp1, RAS guanyl releasing protein 1, [RH, Score=438, Expect=3e-143]} {Dmel: FBgn0034158, CG5522, [Score=95.9, Expect=3e-20]} {Celegans: WBGene00009100, rgef-1, Rap Guanine nucleotide Exchange Factor homolog, [Score=416, Expect=2e-136]} {Smed: dd_Smed_v6_15742_0_2, dd_Smed_v6_15742_0_2, [RH, Score=288, Expect=3e-91]} {RNA1509_53196} {RNA1310_34349} {RNA815_31634} |
26. | MligTC455_08061 | 14 | 0.29 | Mlig455_062790 | Neo: - Age: - |
0.968 | - | - | - | - | - | 0.968 | Mlig455_062790 {REF} {Length: 604} {NoTransDecoderORF} {RNA1310_101890} | |
27. | MligTC455_11257 | 114 | 2.38 | Mlig455_001713 | Neo: - Age: - |
0.968 | - | - | - | - | - | 0.968 | Mlig455_001713 {REF} {Length: 620} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_27830} {RNA815_13308} | |
28. | MligTC455_32028 | 19 | 0.39 | Mlig455_019343, Mlig455_019346 | Neo: - Age: - |
GRIA2 | 0.968 | - | - | - | 0.968 | - | - | Mlig455_019343 {REF} {Length: 3241} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=57.9]; Receptor family ligand binding region [PF01094.30, score=49.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.0]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=1e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=146, Expect=2e-35]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=144, Expect=9e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=144, Expect=1e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=150, Expect=8e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=145, Expect=3e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=3e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=144, Expect=5e-35]} {Dmel: FBgn0039927, CG11155, [Score=158, Expect=1e-39]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=125, Expect=3e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=250, Expect=2e-75]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.1} Mlig455_019346 {REF} {Length: 519} {Pfam: Receptor family ligand binding region [PF01094.30, score=21.5]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.2} |
29. | MligTC455_12847 | 25 | 0.51 | Mlig455_049599 | Neo: - Age: - |
0.967 | - | - | - | 0.967 | - | - | Mlig455_049599 {REF} {Length: 1963} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=67.4]; Olfactory receptor [PF13853.8, score=24.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.1]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [RH, Score=91.7, Expect=1e-19]} {Smed: dd_Smed_v6_35525_0_1, dd_Smed_v6_35525_0_1, [Score=144, Expect=1e-38]} {RNA1310_85894} {RNA815_45174} | |
30. | MligTC455_24568 | 25 | 0.51 | Mlig455_038127 | Neo: - Age: Down-Up-Down |
CACNA2D2 | 0.967 | - | - | - | 0.967 | - | - | Mlig455_038127 {REF} {Length: 4202} {Pfam: von Willebrand factor type A domain [PF13519.8, score=41.5]; von Willebrand factor type A domain [PF00092.30, score=36.2]; von Willebrand factor type A domain [PF13768.8, score=30.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=82.8, Expect=2e-16]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=79.3, Expect=3e-15]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=79.0, Expect=4e-15]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=82.4, Expect=2e-16]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=79.3, Expect=3e-15]} {Celegans: WBGene00007041, tag-180, [Score=62.0, Expect=4e-10]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=430, Expect=2e-140]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
31. | MligTC455_44993 | 102 | 2.13 | Mlig455_068082 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.499 Region-enriched R4: 3.035/0.03492 |
MEN1 | 0.967 | - | - | - | - | - | 0.967 | Mlig455_068082 {REF} {Length: 4679} {TRANSSPLICED} {Pfam: Menin [PF05053.15, score=359.0]} {Human: ENSG00000133895, MEN1, menin 1, [RH, Score=259, Expect=6e-77]} {Mouse: ENSMUSG00000024947, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]; ENSMUSG00000106695, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]} {Dmel: FBgn0031885, Mnn1, Menin 1, [RH, Score=219, Expect=4e-61]} {Smed: dd_Smed_v6_11544_0_1, dd_Smed_v6_11544_0_1, [RH, Score=206, Expect=2e-56]} {RNA1509_25186} {RNA1310_10581.1} {RNA815_3602} |
32. | MligTC455_23209 | 217 | 4.51 | Mlig455_009486 | Neo: - Age: logFC(26M/2M)=-0.272 |
0.966 | - | - | - | 0.966 | - | - | Mlig455_009486 {REF} {Length: 4260} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=57.0]; Endomucin [PF07010.14, score=19.3]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=46.2, Expect=1e-05]} {RNA1509_12774} {RNA1310_9477.1} {RNA815_3474.1} | |
33. | MligTC455_48517 | 682 | 14.21 | Mlig455_004431 | Neo: - Age: - Region-enriched R6: 4.694/0.00066 |
0.966 | - | - | - | 0.966 | - | - | Mlig455_004431 {REF} {Length: 3101} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=112, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_33428} | |
34. | MligTC455_48518 | 1365 | 28.44 | Mlig455_004430, Mlig455_004445 | Neo: - Age: - Region-enriched R6: 4.827/0.00024 |
0.966 | - | - | - | 0.966 | - | - | Mlig455_004430 {REF} {Length: 3275} {Pfam: GDNF/GAS1 domain [PF02351.18, score=23.6]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=113, Expect=2e-25]} {RNA1509_50708} {RNA1310_13399, RNA1509_50708} {RNA1509_50708, RNA815_36630} Mlig455_004445 {REF} {Length: 796} {RNA1509_12695} {RNA1310_66704} {RNA815_33428} |
|
35. | MligTC455_09045 | 28 | 0.58 | Mlig455_030695 | Neo: - Age: - Region-enriched R3: 3.801/0.03726 |
0.965 | - | - | - | - | - | 0.965 | Mlig455_030695 {REF} {Length: 163} {NoTransDecoderORF} | |
36. | MligTC455_43383 | 29 | 0.6 | Mlig455_035092 | Neo: - Age: - |
0.965 | - | - | - | 0.965 | - | - | Mlig455_035092 {REF} {Length: 654} {NoTransDecoderORF} {RNA1310_42279} {RNA815_20885} | |
37. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
0.963 | - | - | - | 0.963 | - | - | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
38. | MligTC455_48591 | 25 | 0.53 | Mlig455_047514, Mlig455_059649 | Neo: - Age: - |
NEUROD1 | 0.963 | - | - | - | - | - | 0.963 | Mlig455_047514 {REF} {Length: 1271} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=54.8]; Neuronal helix-loop-helix transcription factor [PF12533.10, score=51.0]} {Human: ENSG00000162992, NEUROD1, neuronal differentiation 1, [Score=140, Expect=1e-38]; ENSG00000164600, NEUROD6, neuronal differentiation 6, [Score=136, Expect=1e-37]} {Mouse: ENSMUSG00000034701, Neurod1, neurogenic differentiation 1, [Score=139, Expect=1e-38]; ENSMUSG00000037984, Neurod6, neurogenic differentiation 6, [Score=133, Expect=1e-36]} {Dmel: FBgn0010433, ato, atonal, [Score=82.0, Expect=8e-18]} {Celegans: WBGene00000561, cnd-1, Neurogenic differentiation factor 1, [Score=127, Expect=6e-36]} {Smed: dd_Smed_v6_21717_0_1, dd_Smed_v6_21717_0_1, [RH, Score=136, Expect=2e-39]} {RNA1310_133631} {RNA815_38093} Mlig455_059649 {REF} {Length: 945} {Pfam: Neuronal helix-loop-helix transcription factor [PF12533.10, score=20.2]} {RNA1310_133631} {RNA815_38093} |
39. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
0.962 | - | - | - | 0.962 | - | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
40. | MligTC455_13249 | 72 | 1.5 | Mlig455_028005, Mlig455_028032 | Neo: - Age: Up-Down-Up |
IGSF9B | 0.962 | - | - | - | 0.962 | - | - | Mlig455_028005 {REF} {Length: 4846} {Pfam: Immunoglobulin domain [PF13927.8, score=163.0]; Immunoglobulin I-set domain [PF07679.18, score=129.4]; Immunoglobulin domain [PF13895.8, score=110.9]; Immunoglobulin domain [PF00047.27, score=102.5]; Immunoglobulin V-set domain [PF07686.19, score=68.9]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=31.1]; Fibronectin type III domain [PF00041.23, score=27.5]; Izumo-like Immunoglobulin domain [PF16706.7, score=22.6]; Immunoglobulin C1-set domain [PF07654.17, score=22.1]; Immunoglobulin domain [PF18452.3, score=20.9]; Tissue factor [PF01108.19, score=19.1]} {Human: ENSG00000080854, IGSF9B, immunoglobulin superfamily member 9B, [RH, Score=232, Expect=2e-62]; ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [RH, Score=228, Expect=3e-61]} {Mouse: ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [RH, Score=232, Expect=1e-64]; ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [RH, Score=222, Expect=2e-59]} {Dmel: FBgn0010473, tutl, turtle, [RH, Score=250, Expect=5e-70]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [RH, Score=147, Expect=2e-36]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [RH, Score=239, Expect=1e-65]} {RNA1509_10844} {RNA1310_32662} {RNA815_30370} Mlig455_028032 {REF} {Length: 2715} {Pfam: Immunoglobulin domain [PF13927.8, score=136.6]; Immunoglobulin I-set domain [PF07679.18, score=112.1]; Immunoglobulin domain [PF13895.8, score=96.2]; Immunoglobulin domain [PF00047.27, score=94.6]; Immunoglobulin V-set domain [PF07686.19, score=38.5]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=30.1]; Fibronectin type III domain [PF00041.23, score=28.0]; Tissue factor [PF01108.19, score=23.2]; Immunoglobulin C1-set domain [PF07654.17, score=21.7]} {Human: ENSG00000080854, IGSF9B, immunoglobulin superfamily member 9B, [Score=183, Expect=4e-47]; ENSG00000085552, IGSF9, immunoglobulin superfamily member 9, [Score=181, Expect=3e-46]} {Mouse: ENSMUSG00000034275, Igsf9b, immunoglobulin superfamily, member 9B, [Score=184, Expect=2e-47]; ENSMUSG00000037995, Igsf9, immunoglobulin superfamily, member 9, [Score=175, Expect=8e-45]} {Dmel: FBgn0010473, tutl, turtle, [Score=207, Expect=6e-56]} {Celegans: WBGene00020130, igcm-2, ImmunoGlobulin-like Cell adhesion Molecule family, [RH, Score=145, Expect=5e-36]} {Smed: dd_Smed_v6_17743_0_1, dd_Smed_v6_17743_0_1, [Score=203, Expect=2e-54]} {RNA1509_36563} {RNA1310_113619} |
41. | MligTC455_43261 | 41 | 0.86 | Mlig455_065982 | Neo: - Age: - |
0.962 | - | - | - | 0.962 | - | - | Mlig455_065982 {REF} {Length: 581} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
42. | MligTC455_17377 | 32 | 0.67 | Mlig455_041286 | Neo: - Age: - |
0.961 | - | - | - | - | - | 0.961 | Mlig455_041286 {REF} {Length: 912} {NoTransDecoderORF} {RNA1310_106511} | |
43. | MligTC455_23568 | 23 | 0.47 | Mlig455_061665 | Neo: - Age: - |
0.961 | - | - | - | - | - | 0.961 | Mlig455_061665 {REF} {Length: 1787} {NoTransDecoderORF} {RNA1509_10924} {RNA1310_115958} {RNA815_9399} | |
44. | MligTC455_50440 | 23 | 0.47 | Mlig455_061066 | Neo: - Age: - |
0.961 | - | - | - | 0.961 | - | - | Mlig455_061066 {REF} {Length: 3956} {NoTransDecoderORF} {RNA1310_92899} {RNA815_52783} | |
45. | MligTC455_53176 | 54 | 1.13 | Mlig455_051303 | Neo: - Age: - Region-enriched R2: 4.924/0.00950 |
0.961 | - | - | - | 0.961 | - | - | Mlig455_051303 {REF} {Length: 1642} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=25.6]} {Dmel: FBgn0083971, CG34135, [RH, Score=61.6, Expect=7e-11]} {RNA1310_56013} | |
46. | MligTC455_03286 | 26 | 0.55 | Mlig455_000069 | Neo: - Age: - |
0.96 | - | - | - | 0.960 | - | - | Mlig455_000069 {REF} {Length: 265} {NoTransDecoderORF} {RNA1509_23515} {RNA1310_49049} | |
47. | MligTC455_12671 | 38 | 0.79 | Mlig455_038144, Mlig455_039808 | Neo: - Age: - |
0.959 | - | - | - | 0.959 | - | - | Mlig455_038144 {REF} {Length: 650} {RNA1310_68328} {RNA815_32749} Mlig455_039808 {REF} {Length: 815} {RNA1310_68328} {RNA815_32749} |
|
48. | MligTC455_13243 | 15 | 0.32 | Mlig455_056688 | Neo: - Age: - |
0.959 | - | - | - | 0.959 | - | - | Mlig455_056688 {REF} {Length: 422} {NoTransDecoderORF} {RNA1310_142782} | |
49. | MligTC455_13423 | 1243 | 25.9 | Mlig455_044368 | Neo: - Age: logFC(26M/2M)=-0.595 Region-enriched R7: 3.345/0.00033 Regeneration-downregulated BL: -4.170 Regeneration-depleted BL: -4.170 |
0.958 | - | - | - | 0.958 | - | - | Mlig455_044368 {REF} {Length: 544} {RNA1509_13677} {RNA1310_82629.1, RNA1509_13677} {RNA1509_13677, RNA815_40883} | |
50. | MligTC455_25113 | 762 | 15.87 | Mlig455_020768 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.653/0.00004 |
0.958 | - | - | - | 0.958 | - | - | Mlig455_020768 {REF} {Length: 810} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=46.2, Expect=1e-06]} {RNA1509_36958} {RNA1310_50245} {RNA815_48543} | |
51. | MligTC455_06915 | 15 | 0.31 | Mlig455_002666 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_002666 {REF} {Length: 486} {NoTransDecoderORF} | |
52. | MligTC455_10899 | 46 | 0.95 | Mlig455_013784, Mlig455_013915 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_013784 {REF} {Length: 1362} {Pfam: Glycine rich protein [PF12810.9, score=20.8]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} Mlig455_013915 {REF} {Length: 1516} {Pfam: Glycine rich protein [PF12810.9, score=20.3]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} |
|
53. | MligTC455_12494 | 7 | 0.15 | Mlig455_008233 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_008233 {REF} {Length: 1962} {Pfam: F5/8 type C domain [PF00754.27, score=27.4]} {Smed: dd_Smed_v6_46759_0_1, dd_Smed_v6_46759_0_1, [Score=44.7, Expect=6e-06]} {RNA1310_28170} {RNA815_37289} | |
54. | MligTC455_16155 | 68 | 1.41 | Mlig455_036156 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_036156 {REF} {Length: 824} {NoTransDecoderORF} {RNA1509_16255} {RNA1310_42433.1} {RNA815_22226} | |
55. | MligTC455_23808 | 31 | 0.65 | Mlig455_059306 | Neo: - Age: Down-Down-Up |
0.957 | - | - | - | - | - | 0.957 | Mlig455_059306 {REF} {Length: 1845} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=30.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042} | |
56. | MligTC455_38208 | 50 | 1.04 | Mlig455_035776, Mlig455_035887 | Neo: - Age: - |
0.957 | - | - | - | - | - | 0.957 | Mlig455_035776 {REF} {Length: 1950} {NoTransDecoderORF} {RNA1509_38476} {RNA1310_59018} {RNA815_41854} Mlig455_035887 {REF} {Length: 1158} {NoTransDecoderORF} {RNA1509_38476} {RNA1310_73426.1} {RNA815_42145} |
|
57. | MligTC455_40137 | 98 | 2.05 | Mlig455_060068 | Neo: - Age: - Region-enriched R2: 4.909/0.02205 |
IDNK | 0.957 | - | - | - | - | - | 0.957 | Mlig455_060068 {REF} {Length: 2173} {TRANSSPLICED} {Pfam: Shikimate kinase [PF01202.24, score=36.3]; AAA domain [PF13671.8, score=30.7]; AAA domain [PF13238.8, score=26.4]; AAA domain [PF13521.8, score=24.3]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.5]; AAA domain [PF13207.8, score=20.8]} {Human: ENSG00000148057, IDNK, IDNK, gluconokinase, [RH, Score=126, Expect=2e-36]} {Mouse: ENSMUSG00000050002, Idnk, idnK gluconokinase homolog (E. coli), [RH, Score=132, Expect=3e-39]} {Celegans: WBGene00017818, F26D11.1, Gluconokinase, [RH, Score=127, Expect=2e-37]} {Smed: dd_Smed_v6_14936_0_1, dd_Smed_v6_14936_0_1, [RH, Score=108, Expect=2e-30]} {RNA1509_45489, RNA1509_48460} {RNA1310_24189, RNA1509_45489} {RNA1509_45489, RNA815_32058} |
58. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 0.957 | - | - | - | 0.957 | - | - | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
59. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
60. | MligTC455_52113 | 309 | 6.44 | Mlig455_020726, Mlig455_020795 | Neo: Irradiation Age: Up-Down-Down Region-enriched R4: 3.064/0.01451 |
0.957 | - | - | - | 0.957 | - | - | Mlig455_020726 {REF} {Length: 1125} {Smed: dd_Smed_v6_91651_0_1, dd_Smed_v6_91651_0_1, [Score=50.8, Expect=2e-08]} {RNA1509_46103} {RNA1310_6410.3} {RNA815_31889} Mlig455_020795 {REF} {Length: 1037} {TRANSSPLICED} {Smed: dd_Smed_v6_91651_0_1, dd_Smed_v6_91651_0_1, [Score=50.8, Expect=2e-08]} {RNA1509_46103} {RNA1310_6410.3} {RNA815_31889} |
|
61. | MligTC455_37431 | 35 | 0.74 | Mlig455_021017 | Neo: - Age: - |
TMEM268 | 0.956 | - | - | - | 0.956 | - | - | Mlig455_021017 {REF} {Length: 1973} {Pfam: Domain of unknown function (DUF4481) [PF14800.8, score=60.3]} {Human: ENSG00000157693, TMEM268, transmembrane protein 268, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000045917, Tmem268, transmembrane protein 268, [Score=58.2, Expect=8e-09]} {Dmel: FBgn0028527, CG18507, [Score=55.1, Expect=8e-08]} {RNA1310_62734} {RNA815_60695} |
62. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 0.956 | - | - | - | 0.956 | - | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
63. | MligTC455_10771 | 22 | 0.45 | Mlig455_020287 | Neo: - Age: - |
LCK | 0.955 | - | - | - | 0.955 | - | - | Mlig455_020287 {REF} {Length: 6454} {Pfam: Variant SH3 domain [PF14604.8, score=39.7]; SH3 domain [PF00018.30, score=38.4]; SH2 domain [PF00017.26, score=27.6]; Variant SH3 domain [PF07653.19, score=20.7]} {Human: ENSG00000182866, LCK, LCK proto-oncogene, Src family tyrosine kinase, [Score=97.1, Expect=7e-22]} {Mouse: ENSMUSG00000000409, Lck, lymphocyte protein tyrosine kinase, [Score=95.1, Expect=2e-20]} {Dmel: FBgn0262733, Src64B, Src oncogene at 64B, [Score=81.6, Expect=3e-16]} {Smed: dd_Smed_v6_3147_0_1, dd_Smed_v6_3147_0_1, [Score=103, Expect=1e-23]} {RNA1509_5045} {RNA1310_667.1} {RNA815_350} |
64. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 0.955 | - | - | - | 0.955 | - | - | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
65. | MligTC455_19583 | 95 | 1.97 | Mlig455_010583, Mlig455_010602 | Neo: - Age: - Region-enriched R2: 6.442/0.00383 |
0.955 | - | - | - | 0.955 | - | - | Mlig455_010583 {REF} {Length: 2325} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=173.5]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=320, Expect=4e-101]} {RNA1310_36131} {RNA815_32135} Mlig455_010602 {REF} {Length: 2432} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.9]} {Smed: dd_Smed_v6_15099_0_1, dd_Smed_v6_15099_0_1, [RH, Score=346, Expect=2e-110]} {RNA1310_36131} {RNA815_32135} |
|
66. | MligTC455_35418 | 100 | 2.08 | Mlig455_044838 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.788 Region-enriched R2: 3.807/0.02986 |
0.955 | - | - | - | 0.955 | - | - | Mlig455_044838 {REF} {Length: 1117} {Smed: dd_Smed_v6_15147_0_1, dd_Smed_v6_15147_0_1, [RH, Score=135, Expect=6e-35]} {RNA1310_45316.1} {RNA815_39596} | |
67. | MligTC455_53252 | 103 | 2.15 | Mlig455_065173 | Neo: - Age: logFC(26M/2M)=0.345 Region-enriched R2: 3.909/0.00866 |
SYT7 | 0.955 | - | - | - | 0.955 | - | - | Mlig455_065173 {REF} {Length: 2245} {Pfam: C2 domain [PF00168.32, score=157.7]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=262, Expect=2e-80]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=253, Expect=3e-78]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [Score=231, Expect=2e-73]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=180, Expect=8e-54]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=196, Expect=2e-58]} {RNA1509_49257} {RNA1310_13701, RNA1509_49257} {RNA1509_49257, RNA815_8339} |
68. | MligTC455_07826 | 23 | 0.48 | Mlig455_056551 | Neo: - Age: - |
0.954 | - | - | - | 0.954 | - | - | Mlig455_056551 {REF} {Length: 3263} {Pfam: PH domain [PF00169.31, score=23.0]} {RNA1310_46895.1} {RNA815_27323} | |
69. | MligTC455_11951 | 23 | 0.48 | Mlig455_013411 | Neo: - Age: - |
TMEM211 | 0.954 | - | - | - | - | - | 0.954 | Mlig455_013411 {REF} {Length: 1576} {Pfam: Lipoma HMGIC fusion partner-like protein [PF10242.11, score=93.8]} {Human: ENSG00000206069, TMEM211, transmembrane protein 211, [Score=50.4, Expect=5e-07]} {Mouse: ENSMUSG00000041700, Lhfpl1, lipoma HMGIC fusion partner-like 1, [Score=85.1, Expect=2e-19]} {Smed: dd_Smed_v6_9373_0_1, dd_Smed_v6_9373_0_1, [Score=136, Expect=4e-38]} {RNA1310_114675} {RNA815_59257} |
70. | MligTC455_13846 | 32 | 0.67 | Mlig455_013761 | Neo: - Age: - |
CALM2 | 0.954 | - | - | - | 0.954 | - | - | Mlig455_013761 {REF} {Length: 941} {Pfam: EF hand [PF00036.34, score=94.2]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13499.8, score=83.6]; EF hand [PF13202.8, score=77.1]; EF-hand domain pair [PF13833.8, score=42.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.3]; EF-hand domain [PF14658.8, score=23.8]; Ca2+ insensitive EF hand [PF08726.12, score=21.5]; Caleosin related protein [PF05042.15, score=21.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=60.1, Expect=1e-11]; ENSG00000160014, CALM3, calmodulin 3, [Score=60.1, Expect=1e-11]; ENSG00000198668, CALM1, calmodulin 1, [Score=60.1, Expect=1e-11]; ENSG00000178363, CALML3, calmodulin like 3, [Score=59.3, Expect=2e-11]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=60.5, Expect=1e-11]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=60.1, Expect=8e-12]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=60.1, Expect=8e-12]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=59.7, Expect=1e-11]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=60.8, Expect=3e-12]} {Celegans: WBGene00019352, K03A1.4, [Score=70.9, Expect=8e-16]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=97.4, Expect=1e-26]} {RNA1310_47452} {RNA815_31258} |
71. | MligTC455_16050 | 56 | 1.17 | Mlig455_005538, Mlig455_015621, Mlig455_064144 | Neo: - Age: Down-Up-Down |
0.954 | - | - | - | - | - | 0.954 | Mlig455_005538 {REF} {Length: 2036} {RNA1509_38546} {RNA1310_1911.1} {RNA815_61177} Mlig455_015621 {REF} {Length: 2076} {RNA1509_38546} {RNA1310_1911.1} {RNA815_61177} Mlig455_064144 {REF} {Length: 2045} {RNA1509_38546} {RNA1310_1911.1} {RNA815_61177} |
|
72. | MligTC455_20908 | 268 | 5.58 | Mlig455_000262 | Neo: - Age: Up-Down-Down |
NALCN | 0.954 | - | - | - | - | - | 0.954 | Mlig455_000262 {REF} {Length: 6526} {TRANSSPLICED} {Pfam: Ion transport protein [PF00520.33, score=369.8]; Polycystin cation channel [PF08016.14, score=20.1]} {Human: ENSG00000102452, NALCN, sodium leak channel, non-selective, [Score=1434, Expect=0.0]} {Mouse: ENSMUSG00000000197, Nalcn, sodium leak channel, non-selective, [Score=1439, Expect=0.0]} {Dmel: FBgn0002917, na, narrow abdomen, [Score=1431, Expect=0.0]} {Celegans: WBGene00006809, unc-77, Four domain-type voltage-gated ion channel alpha-1 subunit, [Score=1234, Expect=0.0]} {Smed: dd_Smed_v6_7314_0_1, dd_Smed_v6_7314_0_1, [Score=1574, Expect=0.0]} {RNA1509_7317} {RNA1310_530.1} {RNA815_339.1} |
73. | MligTC455_33554 | 32 | 0.66 | Mlig455_005753 | Neo: - Age: - |
0.954 | - | - | - | 0.954 | - | - | Mlig455_005753 {REF} {Length: 2626} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
74. | MligTC455_40084 | 79 | 1.65 | Mlig455_046693 | Neo: Int S/G2/M Age: - |
SNAPC3 | 0.954 | - | - | - | 0.954 | - | - | Mlig455_046693 {REF} {Length: 3322} {TRANSSPLICED} {Pfam: snRNA-activating protein complex (SNAPc), subunit 3 [PF12251.10, score=123.0]} {Human: ENSG00000164975, SNAPC3, small nuclear RNA activating complex polypeptide 3, [RH, Score=84.7, Expect=3e-17]} {Mouse: ENSMUSG00000028483, Snapc3, small nuclear RNA activating complex, polypeptide 3, [RH, Score=89.7, Expect=4e-19]} {Celegans: WBGene00021667, snpc-3.2, SNAPc (Small Nuclear RNA Activating Complex) homolog, [RH, Score=70.9, Expect=4e-13]} {Smed: dd_Smed_v6_9421_0_1, dd_Smed_v6_9421_0_1, [RH, Score=120, Expect=2e-30]} {RNA1509_41696} {RNA1310_22781.3, RNA1509_41696} {RNA1509_41696, RNA815_25555} |
75. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
0.954 | - | - | - | 0.954 | - | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
76. | MligTC455_22077 | 58 | 1.2 | Mlig455_041277 | Neo: - Age: - |
0.953 | - | - | - | 0.953 | - | - | Mlig455_041277 {REF} {Length: 1351} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=30.4]} {RNA1310_27422} {RNA815_33833} | |
77. | MligTC455_28130 | 73 | 1.52 | Mlig455_017884 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_017884 {REF} {Length: 3157} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1} | |
78. | MligTC455_32435 | 68 | 1.42 | Mlig455_025058 | Neo: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_025058 {REF} {Length: 6341} {Mouse: ENSMUSG00000043183, Simc1, SUMO-interacting motifs containing 1, [Score=58.2, Expect=1e-07]} {RNA1509_27520, RNA1509_33149, RNA1509_59656} {RNA1310_50.1, RNA1509_27520, RNA1509_33149, RNA1509_59656} {RNA1509_27520, RNA1509_33149, RNA1509_59656, RNA815_5201} | |
79. | MligTC455_44421 | 36 | 0.74 | Mlig455_016824 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_016824 {REF} {Length: 717} {NoTransDecoderORF} {RNA1310_130476} | |
80. | MligTC455_50332 | 167 | 3.47 | Mlig455_045442 | Neo: - Age: - |
TGFBR1 | 0.953 | - | - | - | 0.953 | - | - | Mlig455_045442 {REF} {Length: 2893} {Pfam: Protein kinase domain [PF00069.27, score=95.1]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=92.0]; ABC1 atypical kinase-like domain [PF03109.18, score=30.4]; Transforming growth factor beta type I GS-motif [PF08515.14, score=20.1]} {Human: ENSG00000106799, TGFBR1, transforming growth factor beta receptor 1, [Score=261, Expect=4e-81]; ENSG00000135503, ACVR1B, activin A receptor type 1B, [Score=254, Expect=3e-78]} {Mouse: ENSMUSG00000007613, Tgfbr1, transforming growth factor, beta receptor I, [Score=263, Expect=3e-82]; ENSMUSG00000000532, Acvr1b, activin A receptor, type 1B, [Score=253, Expect=2e-77]} {Dmel: FBgn0011300, babo, baboon, [Score=259, Expect=3e-79]} {Celegans: WBGene00000897, daf-1, Cell surface receptor daf-1, [Score=187, Expect=1e-51]} {Smed: dd_Smed_v6_3426_0_1, dd_Smed_v6_3426_0_1, [Score=229, Expect=2e-67]} {RNA1509_17304, RNA1509_38608} {RNA1310_10744, RNA1509_38608} {RNA1509_38608, RNA815_11070} |
81. | MligTC455_51285 | 53 | 1.1 | Mlig455_036196 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_036196 {REF} {Length: 840} {NoTransDecoderORF} {RNA1310_62519} | |
82. | MligTC455_35879 | 70 | 1.45 | Mlig455_043343 | Neo: - Age: - |
NR4A3 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_043343 {REF} {Length: 4323} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=109.8]} {Human: ENSG00000119508, NR4A3, nuclear receptor subfamily 4 group A member 3, [RH, Score=168, Expect=1e-44]} {Mouse: ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=173, Expect=2e-45]; ENSMUSG00000028341, Nr4a3, nuclear receptor subfamily 4, group A, member 3, [Score=167, Expect=5e-43]} {Dmel: FBgn0014859, Hr38, Hormone receptor-like in 38, [Score=157, Expect=2e-39]} {Celegans: WBGene00003605, nhr-6, Nuclear hormone receptor family member nhr-6, [Score=148, Expect=6e-38]} {Smed: dd_Smed_v6_12229_0_1, dd_Smed_v6_12229_0_1, [Score=236, Expect=5e-66]} {RNA1509_34082, RNA1509_57832} {RNA1310_20528.1, RNA1509_57832} {RNA1509_57832, RNA815_30713} |
83. | MligTC455_37449 | 92 | 1.91 | Mlig455_046272 | Neo: - Age: Down-Down-Up |
0.952 | - | - | - | - | - | 0.952 | Mlig455_046272 {REF} {Length: 4539} {Pfam: Tetratricopeptide repeat [PF07719.19, score=18.7]} {RNA1509_50803} {RNA1310_4798.1, RNA1509_50803} {RNA1509_50803, RNA815_2540.1} | |
84. | MligTC455_43650 | 38 | 0.8 | Mlig455_053802, Mlig455_068539 | Neo: - Age: - Region-enriched R4: 4.824/0.02628 |
0.952 | - | - | - | 0.952 | - | - | Mlig455_053802 {REF} {Length: 1475} {Pfam: Activin types I and II receptor domain [PF01064.25, score=23.1]} {RNA1310_88727} Mlig455_068539 {REF} {Length: 1648} {Pfam: Activin types I and II receptor domain [PF01064.25, score=21.6]} {RNA1310_88727} |
|
85. | MligTC455_43673 | 77 | 1.61 | Mlig455_022953 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_022953 {REF} {Length: 195} {NoTransDecoderORF} {RNA1310_64101} {RNA815_38499} | |
86. | MligTC455_44647 | 489 | 10.19 | Mlig455_006279 | Neo: - Age: - |
OXSR1 | 0.952 | - | - | - | - | - | 0.952 | Mlig455_006279 {REF} {Length: 2340} {Pfam: Protein kinase domain [PF00069.27, score=128.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=97.0]; Phosphotransferase enzyme family [PF01636.25, score=18.9]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=18.9]; Fungal protein kinase [PF17667.3, score=18.8]} {Human: ENSG00000172939, OXSR1, oxidative stress responsive 1, [Score=89.7, Expect=2e-18]; ENSG00000091436, MAP3K20, mitogen-activated protein kinase kinase kinase 20, [Score=87.0, Expect=1e-17]; ENSG00000135341, MAP3K7, mitogen-activated protein kinase kinase kinase 7, [Score=85.5, Expect=4e-17]} {Mouse: ENSMUSG00000036737, Oxsr1, oxidative-stress responsive 1, [Score=89.7, Expect=1e-18]; ENSMUSG00000028284, Map3k7, mitogen-activated protein kinase kinase kinase 7, [Score=85.5, Expect=3e-17]} {Dmel: FBgn0046689, Takl1, Tak1-like 1, [Score=86.7, Expect=4e-18]} {Celegans: WBGene00006971, zak-1, Mammalian ZAK kinase homolog, [Score=82.0, Expect=3e-16]} {Smed: dd_Smed_v6_2589_0_2, dd_Smed_v6_2589_0_2, [Score=100, Expect=1e-22]} {RNA1509_40362, RNA1509_48119, RNA1509_54731} {RNA1310_1875.2, RNA1509_40362, RNA1509_48119, RNA1509_54731} {RNA1509_40362, RNA1509_48119, RNA1509_54731, RNA815_820} |
87. | MligTC455_11171 | 38 | 0.79 | Mlig455_032767 | Neo: - Age: - |
0.951 | - | - | - | - | - | 0.951 | Mlig455_032767 {REF} {Length: 428} {TRANSSPLICED} | |
88. | MligTC455_25567 | 31 | 0.65 | Mlig455_003495, Mlig455_015560, Mlig455_037973 | Neo: - Age: - |
GLRA4 | 0.951 | - | - | - | - | - | 0.951 | Mlig455_003495 {REF} {Length: 2067} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=19.1]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.9, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=58.2, Expect=1e-08]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=2e-08]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.8, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_1, dd_Smed_v6_14925_0_1, [RH, Score=609, Expect=0.0]} {RNA1310_35073.1} {RNA815_40431} Mlig455_015560 {REF} {Length: 1799} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=19.1]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.9, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=58.2, Expect=1e-08]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=2e-08]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.8, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_1, dd_Smed_v6_14925_0_1, [RH, Score=609, Expect=0.0]} {RNA1310_35073.1} {RNA815_40431} Mlig455_037973 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.4]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.5, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=57.4, Expect=2e-08]} {Mouse: ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=1e-08]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=57.4, Expect=1e-08]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.5, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_2, dd_Smed_v6_14925_0_2, [Score=554, Expect=0.0]} {RNA1310_35073.2} {RNA815_40431} |
89. | MligTC455_27846 | 65 | 1.35 | Mlig455_062268 | Neo: - Age: - |
0.951 | - | - | - | - | - | 0.951 | Mlig455_062268 {REF} {Length: 6610} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=128.3]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=113.8]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=76.6]; Integrase zinc binding domain [PF17921.3, score=71.0]; Integrase core domain [PF00665.28, score=47.5]; Aspartyl protease [PF13650.8, score=38.9]; gag-polyprotein putative aspartyl protease [PF13975.8, score=34.5]; Retroviral aspartyl protease [PF00077.22, score=26.8]; Aspartyl protease [PF09668.12, score=22.8]; Putative peptidase (DUF1758) [PF05585.14, score=21.8]; Retroviral aspartyl protease [PF08284.13, score=18.9]; DDE superfamily endonuclease [PF13358.8, score=18.6]} {Smed: dd_Smed_v6_1574_6_41, dd_Smed_v6_1574_6_41, [Score=335, Expect=6e-100]} {RNA1509_20493} {RNA1310_131.1} {RNA815_52.1} | |
90. | MligTC455_19012 | 73 | 1.52 | Mlig455_023546, Mlig455_023674 | Neo: - Age: - |
CASP3, INVS | 0.95 | - | - | - | - | - | 0.950 | Mlig455_023546 {REF} {Length: 3342} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=84.3]; Ankyrin repeats (many copies) [PF13637.8, score=57.6]; Ankyrin repeats (many copies) [PF13857.8, score=56.9]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeat [PF13606.8, score=50.1]; Caspase domain [PF00656.24, score=45.2]} {Human: ENSG00000119509, INVS, inversin, [Score=67.8, Expect=3e-11]} {Mouse: ENSMUSG00000028344, Invs, inversin, [Score=63.5, Expect=4e-10]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=60.8, Expect=2e-09]} {Celegans: WBGene00000821, csp-3, Non-catalytic caspase homolog csp-3, [RH, Score=56.2, Expect=2e-09]} {Smed: dd_Smed_v6_16314_0_1, dd_Smed_v6_16314_0_1, [Score=52.4, Expect=4e-07]} {RNA1509_53346} {RNA1310_9699} {RNA815_6436} Mlig455_023674 {REF} {Length: 6646} {Pfam: Caspase domain [PF00656.24, score=109.6]; Ankyrin repeats (3 copies) [PF12796.9, score=83.0]; Ankyrin repeats (many copies) [PF13637.8, score=56.3]; Ankyrin repeats (many copies) [PF13857.8, score=55.1]; Ankyrin repeat [PF00023.32, score=54.3]; Ankyrin repeat [PF13606.8, score=48.2]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=107, Expect=2e-25]} {Mouse: ENSMUSG00000031628, Casp3, caspase 3, [Score=101, Expect=3e-23]; ENSMUSG00000025076, Casp7, caspase 7, [Score=96.7, Expect=1e-21]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=89.0, Expect=7e-19]} {Celegans: WBGene00000819, csp-1, Caspase A Caspase A subunit p16 Caspase A subunit p14, [Score=85.1, Expect=4e-18]} {Smed: dd_Smed_v6_4986_0_1, dd_Smed_v6_4986_0_1, [Score=97.1, Expect=2e-22]} {RNA1509_53346} {RNA1310_9699} {RNA815_6436} |
91. | MligTC455_25309 | 27 | 0.56 | Mlig455_007405 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_007405 {REF} {Length: 5652} {RNA1509_20101} {RNA1310_66411} {RNA815_42952} | |
92. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 0.95 | - | - | - | 0.950 | - | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
93. | MligTC455_36485 | 54 | 1.13 | Mlig455_019921, Mlig455_059996, Mlig455_060437 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_019921 {REF} {Length: 215} {NoTransDecoderORF} {RNA1509_26293} {RNA1310_22958} {RNA815_52664} Mlig455_059996 {REF} {Length: 1701} {NoTransDecoderORF} {RNA1509_26293} {RNA1310_22958} {RNA815_52664} Mlig455_060437 {REF} {Length: 4172} {NoTransDecoderORF} {RNA1509_55514} {RNA1310_37194} {RNA815_10967.1} |
|
94. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 0.95 | - | - | - | 0.950 | - | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |